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Abstract
Background: The C-terminus of the serotonin transporter (SERT) contains binding domains for different proteins and is
critical for its functional expression. In endogenous and heterologous expression systems, our proteomic and biochemical
analysis demonstrated that an intermediate filament, vimentin, binds to the C-terminus of SERT. It has been reported that
5HT-stimulation of cells leads to disassembly and spatial reorientation of vimentin filaments.
Methodology/Principal Findings: We tested the impact of 5HT-stimulation on vimentin-SERT association and found that
5HT-stimulation accelerates the translocation of SERT from the plasma membrane via enhancing the level of association
between phosphovimentin and SERT. Furthermore a progressive truncation of the C-terminus of SERT was performed to
map the vimentin-SERT association domain. Deletion of up to 20, but not 14 amino acids arrested the transporters at
intracellular locations. Although, truncation of the last 14 amino acids, did not alter 5HT uptake rates of transporter but
abolished its association with vimentin. To understand the involvement of 5HT in phosphovimentin-SERT association from
the plasma membrane, we further investigated the six amino acids between D14 and D20, i.e., the SITPET sequence of SERT.
While the triple mutation on the possible kinase action sites, S611,T 613, and T616 arrested the transporter at intracellular
locations, replacing the residues with aspartic acid one at a time altered neither the 5HT uptake rates nor the vimentin
association of these mutants. However, replacing the three target sites with alanine, either simultaneously or one at a time,
had no significant effect on 5HT uptake rates or the vimentin association with transporter.
Conclusions/Significance: Based on our findings, we propose that phosphate modification of the SITPET sequence
differentially, one at a time exposes the vimentin binding domain on the C-terminus of SERT. Conversely, following 5HT
stimulation, the association between vimentin-SERT is enhanced which changes the cellular distribution of SERT on an
altered vimentin network.
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Introduction
The serotonin transporter (SERT) is a member of a larger familyof
Na
+- dependent transporters in prokaryotes and animals, which is
designated the SLC6 or NSS family. The biogenic amine transporter
family shares about 60% amino acid identity overall [1–4]. SERT
exists as a 630 amino acid plasma membrane bound glycoprotein in
which both the amino (N) and carboxyl (C) termini are cytosolic.
The termini domains of monoamine transporter proteins have
garnered significant attention for their importance in transport
function and localization. Several proteins have been identified in
association with the C-terminus of SERT such as PICK1 [5–7],
the actin cytoskeleton [8], neuronal nitric oxide synthase, Sec23A,
Sec24C (5), fibrinogen, an activator of integrin aIIbb3 [9].
Additionally, the interaction with MacMARCKS has been shown
to modulate 5HT uptake, endocytosis, and phosphorylation of
SERT via activating protein kinase C (PKC) [10] in a biphasic
manner [11]. Studies have also shown that PKC-dependent
modulation of SERT is correlated with extracellular 5HT levels
[12,13]. More specifically, it has been suggested that the final 20
amino acids of the C-terminal of SERT are critical for the
functional expression of the transporter [14,15].
Our recent findings explained the role of the C-terminus in the
localization and trafficking of SERT via Rab4 a small GTPase, in
a plasma 5HT-dependent manner. These studies demonstrated
that elevated plasma 5HT ‘‘paralyzes’’ the translocation of SERT
from intracellular locations to the plasma membrane by
controlling transamidation and Rab4-GTP formation [15].
PLoS ONE | www.plosone.org 1 March 2009 | Volume 4 | Issue 3 | e4730In endogenous, platelet system, we have also observed the
biphasic effect of plasma 5HT on platelet SERT [16]. More
specifically, in the serum of prehypertensive subjects in which the
plasma 5HT level was slightly higher than physiological levels,
5HT uptake rates and the density of SERT on the platelet plasma
membrane were found significantly higher than those on platelets
from normotensive states [16]. However, in plasma of hyperten-
sive subjects in which 5HT concentration was further elevated, the
5HT uptake rates of SERT was low due to a decrease in the
number of the transporters on the platelet plasma membrane [16].
Importantly, neither the mediators playing a role in 5HT-
dependent regulation of SERT density on the plasma membrane
nor the mechanism by which they are effective on SERT density
as a factor of plasma 5HT-levels have fully been identified yet.
In a series of previously reported experiments, it was found that
5HT-stimulation of cells activates p21 activating kinase (PAK),
which in turn phophorylates vimentin on the serine residue at
position 56 [17]. Following phosphorylation, the curved filamen-
tous structure of vimentin undergoes reorganization and straight-
ens [18]. Therefore, as reported here, we analyzed the vimentin-
SERT association in platelets and then explored the role of plasma
5HT on this association, i.e., whether the disassembly and spatial
reorganization of the vimentin network affects the translocation
and, in turn, the cellular distribution of SERT molecules. Our
biochemical and proteomic analysis of the proteins associated with
the C-terminus of SERT identified vimentin, an intermediate
filament in between many other platelet proteins.
Based on our studies detailed here, we propose that phosphate
modification of the SITPETsequence of SERT one at a time exposes
the C-terminus domain of SERT for vimentin association.
Conversely, following 5HT stimulation, the association between
vimentin-SERT is enhanced specifically on the plasma membrane
which controls the cellular distribution of SERT on an altered
vimentin network.
Materials and Methods
Plasmids, constructs, and cell line expression systems
Human SERT (hSERT) tagged on its amino terminus with
yellow fluorescent proteins (YFP) was studied for the specificities
previously and no significant differences between the 5HT uptake
efficiencies of tagged or wild-type hSERT were observed [15].
The mutant transporters were constructed utilizing a Stratagene
Quickchange XL site-directed mutagenesis kit. The primer
sequences are listed in Table S1. All synthetic constructs were
verified via DNA sequencing.
Cells were grown, and transfection was achieved, as described
previously [19]. To test the impact of 5HT on cellular SERT
system, transfected cells were pretreated with 5HT for 30-min at
room temperature (RT) and then the assays were performed.
Immunofluorescent (IF) analysis
IF imaging cells grown on glass coverslips to 50–60%
confluence in 35-mm dishes were transfected with the respective
plasmids, fixed, stained and imaged after 24 h. We used the 636
oil 1.4 numerical aperture (NA) objective of a LSM510 Zeiss Laser
inverted microscope outfitted with confocal optics for image
acquisition. Subsequent scanning for each individual channel was
performed. YFP was exited at 488 nm with Argon2 laser and
emission was recorded through a 500–530-nm infrared band-pass
filter. Texas Red fluorescence was excited at 543 nm with a
helium-neon laser, and the emitted light was recorded through a
560-nm long-pass filter. Single z-sections were collected (0.8 mm
thick) using Zeiss LSM 510 software (Release Version 4.0 SP1).
Images were cropped with Adobe Photoshop 6.0 software.
5HT Uptake Assay
Transport assays were performed in 24 well plates at RT.
Twenty-four hours after transfection, cells were washed with
phosphate-buffered saline (137 mM NaCl, 2.7 mM KCl, 4.3 mM
Na2HPO4, and 1.4 mM KH2PO4, pH 7.3) (PBS) containing 0.1
mM CaCl2 and 1 mM MgCl2 (PBS/CM). Transport was measured
by incubating the cells in 250 ml of PBS/CM containing the radio-
labeled substrate (1,2-
3H(N))5HT (14.6 nM final concentration;
specific activity) 20.5 Ci/mmol (New England Nuclear, Inc.,
Boston, MA; #NET-498) for 10 min at RT, an interval previously
determined to include only the initial, linear phase of the transport.
Each well was washed very quickly three times with ice-cold PBS.
The cells were lysed in 100 ml of 1% SDS and each well’s contents
were transferred to a scintillation vial and counted in 3 ml of
Scintisafe Econo1 (Fisher Scientific, Pittsburgh, PA) [19].
Background accumulation of (
3H)-serotonin was measured in
the same experiment using mock-transfected cells and subtracted
from each experimental value. Maximum background accumula-
tion was 0.01 pmol/mg protein/min. All determinations were
performed at least in triplicate. Data were then plotted using
OriginLab 7.5 (Northampton, MA), and statistical analyses were
conducted using the NCSS software package (Number Cruncher
Statistical Systems, Kaysville, UT). Analysis of variance (ANOVA)
was used to determine whether mutations or deletions changed
transport activity significantly relative to control or according to
cell line. P-values were adjusted for multiple comparisons using
either Dunnett’s or Bonferroni correction procedures.
Peptide-Affinity Chromatography and Mass Spec Analysis
To identify platelet proteins that interact with the C terminus of
SERT, we used a proteomic approach based on peptide affinity
chromatography by using a synthetic peptide corresponding to the
last 26 amino acids from the C-terminus (586–630) of SERT.
Proteintech Group, Inc. (Chicago, IL) synthesized the peptide and
conjugated to GST Sepharose beads. GST was used as an arm
between peptide and Sepharose to increase the distance between
peptide and matrix to facilitate the interaction between peptide
and the cytosolic protein in the cell lysate. Our control column was
3 ml of GST-Sepharose without peptide. Once we set the peptide-
affinity column, the platelets were isolated and the soluble proteins
were prepared to run on column.
Platelets were isolated from 20 ml blood samples and lysed. 1.0%
TX-100 soluble lysates were loaded on control GST columns and
GST-peptide columns. The proteins bound to the columns were
eluted using 500 mM NaCl and fractions were collected. The peak
fractions were pooled and concentrated on microfilterfuge tubes
with a 10 kD cut off (Rainin Instrument Co., Oakland, CA). The
concentrated samples were resolved by SDS-PAGE. Two major
bands appeared in the peptide-GST Sepharose column but did not
appear in our control, the GST-Sepharose column.
The 115 and 60 kD bands were eluted and processed robotically
using a ProGest instrument (Genomic Solutions), as previously
described [20]. The resultant 50 ml peptide pools were analyzed
using nano LC/MSMS on a LCQ Deca XP Plus ion trap mass
spectrometer.
Western Blot (W/B) Analysis
Cells were solubilized in PBS containing 0.44% SDS, 1 mM
phenylmethylsulfonyl fluoride (PMSF), and protease inhibitor
mixture (PIM). The PIM, which contained 5 mg/ml pepstatin, 50
mg/ml leupeptin, and 5 mg/ml aprotinin, was included with each
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transferred to a nitrocellulose membrane. SERT was detected by
using SERT monoclonal antibody (MAb Technology, Stone
Mountain, GA) (diluted 1:400) and HRP-conjugated anti-mouse
IgG (diluted 1:5,000). The signal was visualized by using an
enhanced chemiluminescence W/B detection system (Pierce,
Rockford, IL). The polyclonal SERT antibody was purchased
from Chemicon International (Temecula, CA; catalog number:
AB1594P).
In W/B analysis, PAK-phosphorylation of vimentin was
detected with a specific vimentin Ser-56 (pS56) antibody (Ab)
[17,18]. pS56-Ab was prepared against a synthetic phosphopep-
tide (Ser-Leu-Tyr-Ala-Ser-phosphoSer56-Pro-Gly-Gly-Ala-Tyr-
Cys) by SynPep Inc. (Dublin, CA). Using standard affinity
purification procedures, pS56A Ab was purified on Protein A
Sepharose column [21]. Vimentin-Ab (Research Diagnostics, Inc.
Concord MA) reacts with vimentin and phosphovimentin dually;
in contrast, phosphovimentin-(pS56)-Ab reacts only with phos-
phovimentin [17].
Cell surface biotinylation
Cell surface expression of the transporters was detected after
biotinylation with the membrane-impermeant biotinylation re-
agent sulfo-NHS-SS-biotin, as described previously [15,19].
Briefly, cells were treated with 100 mM glycine to complete
quenching of the unreacted NHS-SS-biotin and lysed in TBS
containing 1% SDS, 1% TX100, and PIM/PMSF. The
biotinylated proteins (500 ml) were recovered with an excess
amount of streptavidin-agarose beads (400 ml) after overnight
incubation. After biotinylated proteins were eluted in 100 ml
sample buffer and separated on SDS-PAGE, they were transferred
to nitrocellulose and were detected with anti-SERT antibody, as
described [19].
Densitometric scanning of W/B was done on VersaDoc digital
imaging system (BioRad). On each gel, samples were compared
with the biotinylation procedure applied to the same amount of
cells as determined by the BCA protein assay (Pierce, Rockford,
IL). The experiments were performed within the linear range of
densitometry reading of the SERT band as a function of the
amount of protein applied according to control experiments with
varying amounts of protein load per lane. Densitometry data were
captured as total signal in the rectangular area encompassing the
band of study corrected for background; the same rectangular area
was used for estimates of the same band in other lanes of gel.
Results from different scans were uniform.
Results
Vimentin and phosphovimentin associate with SERT in
platelets
A synthetic peptide corresponding to the last 26 amino acids
from the C-terminus (586–630) of SERT was conjugated to GST
Sepharose beads. As described in the Methods section, the GST
was used as an arm between the peptide and Sepharose to increase
the distance between the peptide and matrix to facilitate the
interaction between the peptide and the cytosolic protein in the
cell lysate. Detergent solubilized platelet lysate was run on the
peptide-affinity column. The proteins bound to the columns were
eluted and concentrated on microfilterfuge tubes with a 10 kD cut
off. The concentrated samples were resolved by SDS-PAGE (data
not presented). Two major 115 and 60 kD bands appearing in the
peptide-GST but not control GST-column were eluted, processed,
and analyzed using nano LC/MSMS on a LCQ Deca XP Plus ion
trap mass spectrometer as previously described [20]. Our
proteomic approach identified vimentin as one of many platelet
proteins bound to the C-terminus of SERT. Furthermore, we
analyzed these findings with biochemical techniques following the
endogenous expression of vimentin and SERT in platelets with
W/B assays (Fig. 1A). The co-IP assays agreed with our ESI-MS/
MS mass spectrometry result showing the association between
vimentin and SERT in platelet (Fig. 1B and C).
It is reported that stimulation of cells with 5HT induced
phosphorylation of vimentin on serine at position 56, resulting in
the reorganization of the vimentin network [17,18]. Consequently,
we investigated the impact of 5HT stimulation on vimentin-SERT
association. Platelets in platelet poor plasma (PRP) were first
stimulated with 1 or 2 nM 5HT, which represents the plasma
levels of 5HT in normotensive and hypertensive patients,
respectively, and thus a physiologically relevant stimulus [16].
Following a 30-min pretreatment with 5HT at RT, platelets were
pelleted, lysed in IP-lysing buffer, and precleared [19]. The platelet
lysate was divided into two half portions. The IP assay was
performed on both portions using either a monoclonal vimentin-
Ab or monoclonal SERT-Ab.
The proteins precipitated on vimentin-Ab were subjected to
immunoblot analysis using anti-SERT Ab (Fig. 1B). The level of
SERT on vimentin-Ab was increased in a 5HT concentration-
dependent manner. Stimulation of platelets with 2 nM 5HT
enhanced SERT-vimentin association in whole platelet signifi-
cantly (Fig. 1B).
Since 5HT-stimulation of cells leads to the phosphorylation of
vimentin on the Serine56 residue which alters the filamentous
structure of this cytoskeletal protein [17,18], the reorganization of
the vimentin network should regulate the translocation of proteins
that utilize the vimentin network [18]. Therefore, we next
evaluated the impact of 5HT stimulation on SERT-phosphovi-
mentin association in order to understand the involvement of
phosphovimentin in the translocation process of SERT.
We then analyzed the proteins precipitated on SERT-Ab by
W/B using a polyclonal phosphovimentin-(pS56)-Ab, which reacts
only with the phosphovimentin (Fig. 1C). In contrast, vimentin-Ab
dually reacts with vimentin and phosphovimentin [17].
pS56-Ab identified a major band around 55 kD only in 2 nM
5HT pretreated platelet lysate. Thus, these data demonstrate the
presence of an association between SERT and phosphovimentin
(Fig. 1C).
Therefore, the level of association between vimentin and SERT
in Fig. 1B and C represents the total intracellular and plasma
membrane. Overall, these findings show that vimentin associates
with SERT in an endogenous system, the platelet. Their
association was not due to 5HT-dependent stimulation of the
platelet; even in the unstimulated form, vimentin-SERT associa-
tion can be detected (Fig. 1B). However, when the level of 5HT
was increased to 1 nM, the precipitated amount of vimentin on
SERT was also elevated; therefore, 5HT enhances vimentin-
SERT association (Fig. 1B). In the presence of 2 nM 5HT when
vimentin is phosphorylated, a high affinity association between
SERT and phosphovimentin was observed (Fig. 1C). Additionally,
the levels of vimentin and SERT in the whole platelet lysate were
not altered at different 5HT concentrations (Fig. 1D).
Since the co-IP assays demonstrated that 5HT-stimulation
enhanced the association between vimentin and SERT in platelets,
we next addressed (i) whether their association was limited to
intracellular locations or also occurred on the plasma membrane;
(ii) whether 5HT-dependent elevation of phosphovimentin-SERT
association also occurred on the plasma membrane. We performed
surface biotinylation followed by W/B assays on platelets
stimulated with different concentrations of 5HT.
5HT Alters SERT Translocation
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platelets plasma membrane
To determine the involvement of phosphovimentin in the
density of SERT on platelet plasma membrane, platelets in PRP
were first pretreated with 5HT (0–2 nM) for 30 min at RT, then
the pelleted platelets was biotinylated with membrane imperme-
able NHS-SS-biotin [16]. Biotinylated platelet plasma membrane
proteins were retrieved on streptavidin beads and eluted from the
beads.
Half of each biotinylated sample was subjected to immunoblot
analysis using anti-SERT Ab (Fig. 2A). The biphasic effect of
plasma 5HT on the density of SERT on platelet plasma
membrane was observed, as seen previously in hypertension
model systems [16]. An intermediate level (1 nM) 5HT-stimulation
increased the density of SERT on the platelet; however, at high
level (2 nM), 5HT-stimulation lowered the surface density of
SERT compared to untreated platelets [15,16].
Here, our data demonstrate that the association between SERT
and vimentin is altered in a 5HT-dependent manner. Therefore,
here we tested whether the cellular distribution of SERT is altered
by 5HT-dependent phosphorylation of vimentin. The level of
phosphovimentin on the plasma membrane 5HT-stimulated
platelet was evaluated.
The other half of the biotinylated platelet plasma membrane
proteins was subjected to immunoblot analysis with pS56-Ab
(Fig. 2B). Phosphovimentin appeared as one of the proteins
associated with biotinylated plasma membrane-bound proteins in
5HT-stimulated platelets.
SERT could be one of the other phosphovimentin-associated
membrane proteins, but our co-IP data in 5HT-stimulated platelets
also demonstrated an elevation in the association of SERT-
phosphovimentin in whole platelet (Fig. 1C). Therefore, we tested
SERT-phosphovimentin association in 5HT-stimulated platelets.
The effects of 5HT-stimulation on the amount of intracellular
SERT (flow through of the streptavidin beads) mirrored those of
the cell surface SERT (Fig. 2C and D).
Previously, it has been shown that 5HT-stimulation phosphory-
lates vimentin on the Serine56 residue, but the vimentin S56A
mutantisnot phosphorylated by5HT-stimulation [18].Therefore,to
mechanistically determine how the vimentin-SERT association
responds to 5HT for regulating the distribution of transporter
molecules between plasma membrane and intracellular locations, the
Figure 1. SERT and vimentin interaction in human platelets. (A) Endogenous vimentin and SERT expression in platelets were analyzed with
W/B analysis. The association between vimentin and SERT was determined by a co-IP in platelets stimulated with 0, 1, and 2 nM 5HT. Following 5HT-
stimulation, platelet lysate was divided into two portions; the half portion of lysate was incubated in anti-vimentin monoclonal Ab (B), the other half
portion in anti-SERT Ab coated protein A Sepharose beads (C). Next day, vimentin- or SERT-Ab pulled down proteins were eluted from sepharose
beads; both IP eluents were analyzed either with a polyclonal SERT Ab, or with pS56-Ab, respectively. Nonspecific adsorption of Sepharose beads was
not determined in the absence of antibodies. The association between endogenous vimentin and SERT was altered in a 5HT concentration-
dependent manner. The highest amount of SERT was pulled down by vimentin-Ab in 2 nM 5HT-stimulated platelets. Additionally, vimentin
associated with SERT after 2 nM-5HT stimulation was in phosphorylated form. (D) Expression of SERT and vimentin in total cell lysates was determined
by W/B analysis as a loading control. All lanes contain protein recovered from the same number of platelets (1.5610
8). Figures show representative
images from 2 to 4 separate experiments.
doi:10.1371/journal.pone.0004730.g001
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studied in a CHO heterologous expression system. Obviously, not all
aspects of 5HTbiology in platelets can be recapitulated in CHO cells,
but the CHO model system allows for the analysis of the association
between vimentin and the C-terminus truncated forms of SERT and
the nonphosphorylated mutant form of vimentin S56A.
To ascertain the optimal 5HT concentration required to stimulate
CHO cells expressing hSERT (CHO-hSERT), we measured the
density of SERT proteins on the plasma membrane of CHO-hSERT
cells and compared this finding to human platelet membranes using
biotinylation [15]. In this previous study, we tried to model the effect
of plasma 5HT on platelet SERT in a heterologous expression
system. Simply stated, an equal amount of biotinylated membrane
proteins from CHO-SERT cells and platelets were resolved and
analyzed by W/B using SERT-Ab. These calculations together with
the dose response analysis of CHO cells to 5HT-stimulation which
was already conducted in our previous studies showed that the
expression of SERT on the plasma membrane of CHO-SERT cells
was 59-fold higher than on the platelet membrane [15]. This
estimation indicated that the effect of plasma 5HT at a concentration
of 1 nM on platelet SERT may correspond to exogenous 5HT at a
concentration of ,45 mM on CHO-SERT cells [15].
Co-localization of Vimentin and SERT with or without
5HT stimulation
For the current study, we took a second approach for testing the
association between phosphovimentin and SERT on the plasma
membrane of 5HT-stimulated cells.
The co-localization of the red vimentin and green YFP-SERT
signals were captured in the overlaid images with YFP and Texas
Red filter sets. If vimentin and SERT co-localized then the
structures would appear light orange; otherwise, the distinct green
and red signals would represent structures containing either one of
the two proteins. Fifty cells were examined for colocalization of
vimentin and SERT following 5HT stimulation. In all YFP-SERT
transfected cells, a limited but consistent co-localization between
vimentin and SERT on the plasma membrane was seen (Fig. 3).
The colocalization of endogenously expressed vimentin and
transiently expressed SERT was monitored in 5HT-stimulated
CHO-(YFP-SERT) cells using IF microscopy. The cellular
distribution of vimentin was significantly different in 5HT-
stimulated cells than in control cells. To facilitate a comparison
between the localization of SERT and vimentin, the SERT signal
was pseudocolored in green in merged images. 5HT stimulation
mostly located vimentin around the plasma membrane. Exposure
of CHO-YFP-hSERT to 5-HT induced the spatial reorientation of
vimentin filaments (Fig. 3). In control cells, vimentin exhibited a
curved filamentous appearance (Fig. 3, control panel, insert).
Vimentin filaments became more straight and bundled 30 min
after stimulation with 100 mM 5HT (Fig. 3, 5HT-treated cells
panel, insert).
Vimentin binding domain on the C-terminus of SERT
The C-terminus of the biogenic amine transporter plays a
critical role in the regulation of transporter function and
intracellular trafficking [5–15]. Our proteomic studies identified
the C-terminus of SERT as a vimentin binding domain on SERT.
To map the vimentin binding sequence on the C-terminus of
SERT, we utilized the truncated form of transporters, D26, D20,
D14, and D6 [15]. As we reported in a previous study, the 5HT
uptake rates and the levels of surface expression of D6 and D14 of
SERT were similar to the wild-type transporter [15]. These results
were not due to altered protein translation as evident by W/B and
densitometry analysis showing that the band densities of all
constructs were similar [15].
Next, the association between endogenously expressed vimentin
and transiently expressed truncated forms of transporters were
tested in 5HT-stimulated CHO cells with IP analysis (Fig. 4). The
cellular proteins on the vimentin-Ab coated protein A beads were
eluted and separated on SDS-PAGE followed by immunoblotting
with SERT-Ab (Fig. 4). The major band at 90 kD was detected in
the CHO-SERT and -D6 cells (Fig. 4).
Our recent study compared the distribution of these truncated
YFP-SERT variants with that of Texas Red conjugated wheat
germ agglutinin (WGA), a lectin marker for the plasma membrane
[15]. The IF analysis and 5HT uptake rates showed a lack of
colocalization between D26 and D20 and plasma membrane [15].
Although deletion of up to 20, but not 14 amino acids arrested the
transporters at intracellular locations [15], D14 like the other two
mutants, D20 and D26, did not co-IP with vimentin (Fig. 4). These
data identify the residues 616–624 in the SERT protein backbone
as an essential domain for vimentin association.
Characterization of SITPET sequence of SERT
Inspection of the six amino acid difference between D20 and
D14, the SITPET sequence, revealed 3 amino acids, S611, T613,
and T616 as possible kinase action sites. We began to assess the
effect of mutations of these 3 residues on uptake activity, whole
cell, and surface expression. At each of the targeted locations, the
original amino acid was changed to an alanine or aspartic acid
(Fig. 5A).
Figure 2. Effect of 5HT stimulation on SERT-vimentin associ-
ation on platelet plasma membrane. 0–2 nM 5HT-stimulated
platelets were biotinylated with NHS-SS-biotin [15,16,19], and biotiny-
lated plasma membrane proteins were retrieved on streptavidin beads.
Half of biotinylated platelet membrane proteins were analyzed for SERT
(A), and the other half was analyzed for anti-phosphovimentin-Ab
(pS56-Ab) (B) with W/B. Neither SERT not pS56-Ab detected recogniz-
able proteins in mock biotinylated controls (carried through the
biotinylation procedure without the addition of the biotinylation
reagent); therefore, they are not presented in the blots. Plasma 5HT
levels had a biphasic effect on the plasma membrane expression of
platelet SERT [16]. To correlate SERT-phosphovimentin association on
the surface density of platelet SERT, the biotinylated platelet membrane
proteins were analyzed with pS56-Ab. Plasma 5HT, only at high level,
showed an association between phosphovimentin-SERT. Intracellular
SERT (C) and vimentin (D) were determined by W/B analysis of non-
bound material and also served as a loading control. All lanes contain
protein recovered from the same number of platelets (1.5610
8). Figures
show representative images from 3 separate experiments.
doi:10.1371/journal.pone.0004730.g002
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change to aspartic acid acts as a phospho-mimic at the site of
mutation due to the charge and shape of the carboxylic acid
functional group. 5HT uptake rates of each construct, S611A,
T613A,T616A,andthetriplemutation(AAA)retained 90,74,100or
95% of the activity of wild-type transporter, respectively (Fig. 5A).
However, the single mutation of S611D caused a dramatic
decrease in the uptake activity of SERT, reducing transport
capacity to approximately 38%, whereas T616D caused no
noticeable change in uptake function (Fig. 5A). Furthermore, the
triple mutation to aspartic acid (DDD) caused a 95% reduction in
the 5HT uptake capacity of SERT (Fig. 5A), possibly indicating a
synergistic relationship between these three positions. In all cases,
changes in transport capacity were not the result of altered protein
expression levels, as indicated by W/B and densitometry analysis
of total protein blots (Table 1).
Investigation into the role of S611 in the 5HT uptake capacity
of SERT was analyzed using the S611A and S611D constructs
originally produced, while DD and AA, i.e., the double mutation
of T613 and T616, were constructed to investigate the role of the
two threonine residues in the proposed mechanism. S611
appeared to exert the most influence on the 5HT uptake rate of
SERT.
Next, the expression of SITPET mutants on the plasma
membrane was assessed by their colocalization with WGA, a
plasma membrane marker (Fig. 5B). Mutants YFP-SERT variants
were expressed in CHO cells and their distribution was compared
with that of Texas Red conjugated wheat germ agglutinin, a lectin
marker for the plasma membrane. The fluorescence data shown in
Figure 5B indicate that the majority of DD and DDD were
associated with intracellular structures. A significant part of AAA
localized to the plasma membrane. Although a noteworthy pool of
S611D appeared internally, some of S611D was observed on the
plasma membrane (Fig. 5B).
In summary, DDD and DD were predominantly found at
intracellular compartments while S611D located on the plasma
membrane partially and mostly at intracellular compartments.
Thus, the S611D transporter apparently has difficulties in
Figure 3. Vimentin-SERT co-localization and impact of 5HT-stimulation on their cellular distribution. CHO-YFP-SERT cells were
pretreated with 5HT as indicated, labeled with vimentin monoclonal Ab, and stained with Texas Red conjugated rabbit IgG. In unstimulated cells,
vimentin revealed curved filamentous structures; in 5HT-stimulated ones the vimentin filaments became straight as indicated with arrows. Cells were
analyzed with a Zeiss LSM510 laser confocal microscope. To contrast the localization of SERT and vimentin, the overlaid images are presented with
SERT signal pseudocolored in green. The bar (10 mm) indicates the magnification of the main figures; the insets are 26the magnification of the main
figures. Figures show representative images from at least 2 separate experiments.
doi:10.1371/journal.pone.0004730.g003
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the plasma membrane (Fig. 5B and Table 1).
In an effort to explore the six amino acid difference between
D20 and D14, the SITPET sequence, we began tested the
association between endogenously expressed vimentin and tran-
siently expressed mutant forms of transporters in 5HT-stimulated
CHO cells with IP analysis (Fig. 6). The cellular proteins on the
vimentin-Ab coated protein A beads were eluted and separated on
SDS-PAGE followed by immunoblotting with SERT-Ab (Fig. 6).
The major band at 90 kD was detected in the CHO-SERT,
T613D, -T616D, and -AAA cells (Fig. 6). The 5HT uptake rates and
the levels of surface expression of these forms were similar to the
wild-type transporter (Fig. 5). Subsequently their levels of
association with vimentin were high as well. On the other hand,
the mutant that had a very minimal 5HT uptake rate and plasma
membrane such as DDD did not associate with vimentin. Based
on these findings, we hypothesize that the vimentin-binding ability
of transporter is correlated with the density of transporter on the
plasma membrane. In deed, S611D neither fully appeared on the
plasma membrane, nor was pulled down by anti-vimentin
antibody (Fig. 6). The 5HT uptake rate and the density of
S611D on the plasma membrane (approximately 30% of the wild-
type, Table 1) showed a similar pattern with its vimentin binding
ability. The level of S611D precipitated on vimentin-Ab was 30%
of the level of wild-type on vimentin-Ab.
Vimentin-SERT Association on the plasma membrane
Next, we evaluated the impact of 5HT stimulation on the
density of truncated and mutant forms of transporters on the
plasma membrane. CHO cells expressing D26, D20, D14, D6,
S611D, T613D, T616D, AAA, and DDD were either directly
(Fig. 7A, B ) or after stimulation with 100 mM 5HT (Fig. 7C, D)
subjected to the cell surface biotinylation assay. Biotinylated
membrane proteins were pulled down on streptavidin beads and
eluted from the beads in SDS-PAGE sample buffer.
One half of the biotinylated membrane proteins were blotted
with anti-SERT-Ab (Fig. 7A). Although there was some decrease
in the densities of transporters on the plasma membrane of S611D
transfected cells, D26, D20, and DDD were not located on the
plasma membrane at all (Fig. 7A).
To evaluate the association of vimentin and the truncated and
mutant transporters on the plasma membrane, the second half of
the same biotinylated samples were subjected to immunoblot
analysis with vimentin-Ab (Fig. 7B). In untransfected cells our W/
B analysis recognized the endogenous vimentin as one of the
proteins pulled by the biotinylated plasma membrane-bound
proteins (Fig. 7B, the lane labeled as NoDNA). Therefore, it is
clear that vimentin had bound other plasma membrane proteins as
well as SERT.
In SERT transfected cells, the level of vimentin on the plasma
membrane was much higher than the untransfected ones. This
finding identifies SERT as one of the membrane-bound proteins
that links vimentin to the plasma membrane. Similarly, the levels
of vimentin on the plasma membrane of D26, D20, D14, and
DDD transfected cells were the same as that on the plasma
membrane of untransfected cells (Fig. 7B). This finding suggests a
lack of association between vimentin and D26, D20, D14, or DDD
on the plasma membrane. On the other hand, the vimentin-
binding abilities of T616D and T613D on the plasma membrane
were very similar to CHO-SERT and CHO-D6 cells.
The levels of vimentin on the plasma membrane of S611D
transfected cells was lower than that in wild-type transfected cells
but higher than that in untransfected ones. These findings are in
good agreement with the data in Figure 6. Collectively, they
support our hypothesis that the density of transporter on the
plasma membrane and the level of its vimentin binding are
correlated.
In summary, SERT is one of the proteins that link vimentin to
the plasma membrane. Our co-IP studies in endogenous and
heterologous expression systems, and IF analyses (Fig. 1, 3)
demonstrate that in 5HT stimulated platelets the level of SERT
precipitated on vimentin-Ab is higher than that in control
platelets, which were altered by the extracellular level of 5HT.
We [15,16] and others [11,12] reported that 5HT stimulation at
high levels does not increase the 5HT uptake rates and the density
of SERT on the plasma membrane. Thus, we attempted to
determine: (i) whether extracellular 5HT at high levels facilitates
the translocation of SERT from the plasma membrane via
phosphovimentin; and (ii) modification of three C-terminus
residues, S611D, T613D, T616D, are involved in phosphovimen-
tin-SERT association (Fig. 7C and D).
CHO cells expressing truncated and mutant forms of SERT
were first stimulated with 100 mM 5HT, and then biotinylation
assay was performed to separate the plasma membrane proteins
and their partners. Biotinylated membrane proteins were pulled
down on streptavidin beads and eluted from the beads in SDS-
PAGE sample buffer.
One half of the biotinylated membrane proteins were blotted
with anti-SERT-Ab (Fig. 7C). In agreement with reported studies,
a pretreatment with 100 mM 5HT did not elevated the densities of
SERT, D6, and the mutant transporters that mimic the
phosphorylated forms, T613D and T616D, as 10 mM 5HT-
stimulation did [15]. However, 5HT-stimulation increased the
density of D14 truncated transporter and did not change the
density of S611D mutant transporters on the plasma membrane
(Fig. 7C).
In exploring the impact of phosphovimentin-SERT association
on the plasma membrane density of SERT, the second half of the
same biotinylated samples were subjected to immunoblot analysis
with pS56, phosphovimentin-Ab (Fig. 7D). The data indicated that
Figure 4. Vimentin binding domain on the C-terminus of SERT.
CHO cells expressing the indicated SERT constructs were lysed and
prepared for IP. The cell lysate was incubated with monoclonal anti
vimentin-Ab coated protein A sepharose beads. The presence of SERT
truncations was detected with a polyclonal SERT Ab (Chemicon
International). Since SERT-D6 bound to vimentin and the other
truncations, we proposed that the amino acids 616–624 are at least
one of the vimentin binding domains on the C-terminus of SERT.
Nonspecific adsorption of Sepharose beads was not determined in the
absence of vimentin-Ab and the data obtained from this set of
experiment is not presented here since it can be found in Figure 1B. All
lanes contain protein recovered from the same number of cells
equivalent to 30% of one well from a confluent 24-well culture plate.
Figure shows representative images from 3 separate experiments.
doi:10.1371/journal.pone.0004730.g004
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PLoS ONE | www.plosone.org 8 March 2009 | Volume 4 | Issue 3 | e4730the association affinity between SERT and phosphovimentin on
the plasma membrane was enhanced by 5HT stimulation.
The mutants, AAA, T613D, T616D, and the truncated form of
the transporter, D6, which show decreased densities on the plasma
membrane in response to 5HT stimulation, associated with
phosphovimentin with high affinity (Fig. 7D). 5HT-stimulation
does not alter the cell surface expression of S611D significantly or
its association with phosphovimentin.
In these experiments, we included two control experiments: (i)
mock biotinylated CHO cells transfected with SERT; and (ii)
mock transfected CHO cells. The first control, mock biotinylated
CHO cells, were carried through the biotinylation procedure
without the addition of the biotinylation reagent and none of
antibodies, SERT-, vimentin- nor pS56-Abs, recognized proteins
from these blots (data not presented). The next control, mock-
transfected cells, allowed us to observe (i) the nonspecific
adsorption of Sepharose beads and the proteins from the detergent
soluble platelet lysate; (ii) if 5HT mediate any of these nonspecific
interactions.
The total phosphovimentin and vimentin (as flow through of the
streptavidin beads) was similar between truncated and mutant
forms of transporter expressing CHO cells (Fig. 7E and F).
The levels of vimentin and phosphovimentin in cell lysate of 100
mM 5HT-stimulated cells show if the associations between these
proteins with SERT or truncated/mutant forms are altered with
the differences in their levels, and/or with 5HT stimulation
(Figure 7E and F).
Overall, these data suggest that the 5HT-dependent decrease in
the surface expression of SERT directly correlates with its binding
to phosphovimentin. Therefore, we hypothesize that in cells
stimulated with a high level of 5HT, the surface density of SERT is
decreased due to an increase in its association with phosphovi-
mentin. In exploring this hypothesis, we tested the 5HT uptake
rates and level of SERT on the cell surface in CHO cells
transfected with 5HT-dependent phosphorylation site mutant
vimentin, S56A and SERT.
The impact of 5HT-stimulation on plasma membrane
density of transporter
The amount of SERT on the plasma membrane is one of the
important factors in determining the 5HT uptake rates of cells,
which is controlled in a dynamic manner by the relative rates of
transporter recycling from endosomes and internalization from the
cell surface. In evaluating the role of phosphovimentin-SERT
association on the surface expression of transporter, CHO cells co-
expressing SERT and the vimentin S56A mutant were used in
biotinylation assays followed by quantitative W/B either with
SERT- or with pS56-Ab (Fig. 8A).
The plasma membrane density of SERT in CHO-SERT cells
stimulated with 100 mM 5HT appeared lower than in cells
stimulated with 10 mM 5HT. The quantification of these data is
summarized in Table 2.
Stimulation with 10 mM 5HT increased the density of SERT on
the plasma membrane of CHO-SERT cells 44.4%, whereas 100
mM 5HT stimulation did not show this enhancement on the
density of SERT on the plasma membrane compared to untreated
CHO-SERT cells. At high concentrations, 5HT stimulation
reduced the plasma membrane density of SERT and resulted in
a loss of uptake function in platelet system (30%) that was more
severe than that in the heterologous system (5.7%). Apparently,
these differences are due to the factors involved in the
translocation of SERT from/to the plasma membrane, which
are either not found in endogenous and heterologous expression
systems equally, or the expressions levels in both systems are not
stochiometrically sufficient to play their roles correctly.
Additionally, the immunoblots revealed that in cells stimulated
with 100 mM 5HT, the transporters bound significant amounts of
phosphovimentin on the plasma membrane (Fig. 8A).
Next, we tested the impact of SERT-phosphovimentin associ-
ation on the plasma membrane density of SERT. CHO cells were
co-transfected with SERT and pS56A constructs, stimulated with
10 or 100 mM 5HT, and then subjected to cell surface
biotinylation. Immunoblots of the biotinylated membrane proteins
demonstrated that in the absence of phosphovimentin, 100 mM
5HT-stimulation kept the plasma membrane density of SERT at
the level found in 10 mM 5HT-stimulated levels (Fig. 8A and B).
We wanted to follow up these findings by correlating the
biochemical characteristics of CHO-(SERT+pS56A) cells with
their 5HT uptake measurement (Fig. 8C). Cells co-expressing the
phosphorylation mutant form of vimentin, pS56A and transporter,
did not reveal the wild-type phenotype of 5HT-downregulated
5HT uptake. In this respect, they behaved identically to the cells
stimulated with 10 mM 5HT.
Discussion
The plasma membrane level of SERT is altered by the rate of
the translocation transporter protein to/from the plasma mem-
brane which is controlled through its interaction with other
proteins in these pathways. It was well documented that the
plasma level of 5HT plays a role in the density of SERT on the
plasma membrane via PKC-mediated phosphorylation of SERT
[12,22]. Additionally, the C-terminus region of SERT is vital to
the ability of these transporters to function [14]. Our studies here
identify a novel pathway by correlating how plasma 5HT plays a
role on the translocation of SERT from the plasma membrane via
using the C-terminus region of transporter.
Figure 5. (A) 5HT uptake rates of SITPET mutants. Twenty-four hour post-transfection CHO cells were washed and assayed for analysis of 5HT
uptake rate. Background accumulation of (
3H)-serotonin was measured in the same experiment using mock-transfected cells and subtracted from
each experimental value. Maximum background accumulation was 0.01 pmol/mg protein/min. Phospho-mimicking mutations in the C-terminal
region caused mixed results. The S611D mutation resulted in the most significant change over its neutral counterpart, S611A. Another key point is the
drastic reduction seen when all 3 sites were mutated to aspartic acid and when only the two threonines were mutated to aspartic acid. Bars represent
means6SD of three or more independent experiments. ANOVA indicated that the effect of the construct was highly significant (p,0.001). Multiple
post-hoc comparisons versus control (SERT) were made applying Dunnett’s correction; values marked with (**) were significantly different from
control at p,0.05. Expression of SITPET mutants. The trafficking of mutants was assessed by gel electrophoresis and W/B. The detergent extracts
of total protein were analyzed to determine if the alteration in uptake ability was due to alterations in the amount of protein. All variations of the
transporter demonstrated similar protein expression levels. All lanes contain protein recovered from the same number of cells equivalent to 30% of
one well from a confluent 24 well dish. The loading control was performed with actin (inset in the figure). The immunoblots are representative of at
least three independently performed experiments. (B) Colocalization of YFP-SERT mutants on the plasma membrane. Cells were stained with
Texas Red-WGA to mark the plasma membrane. The images show that DD and DDD mutations were totally retained on intracellular structures; S611D
was found partially on the intracellular compartments. However, AAA and T613D were predominantly on the plasma membrane (arrowheads), but a
pool of them resided on intracellular organelles. A 1 mm bar is presented for the image set.
doi:10.1371/journal.pone.0004730.g005
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its interaction with other proteins such as an adaptor protein, Hic-
5 plays a role in the internalization of SERT in platelets [13]. Also,
the C-terminal region of SERT was identified as a domain of
interaction with the actin cytoskeleton [8]. Relevant findings
include that the C-terminal of SERT interacts with Mac-
MARCKS, a substrate of PKC that binds to the actin
cytoskeleton, and the fact that PKC modulators, such as b-
PMA, modulate the activity of SERT [8,10,11,23]. Our data
further support this contention by demonstrating that C-terminal
truncated forms of SERT show a loss of functional membrane
trafficking. This loss of function may relate to the level of interact
between SERT and cytoskeleton network.
Our studies with SERT in transient transfection systems reveal
that the truncation of various lengths of the C-terminus altered the
5HT uptake rate of SERT transporters. Truncation of the final 26
and 20 amino acid residues of SERT completely abolished uptake,
whereas truncation of the final 14 and 6 residues resulted in a 12%
to 18% loss in transport capacity as compared to full length SERT.
These results agree with published reports for NET and SERT
[14,24, respectively], which demonstrate that truncation of the C-
terminus abolished the uptake rates of these transporters. However,
a single residue removal from the C-terminus of NET caused a 60%
reduction in uptake capacity [24]. Here, we demonstrate that
truncation of the final 14 residues of SERT resulted in a transporter
that still retained approximately 90% of its 5HT uptake rate.
Further analysis of the difference between D20 and D14
truncations of the SERT C-terminus, which retained 0%
compared to 90% transport rates, respectively, revealed the
sequence SITPET. Within this region, there are 3 potential
phosphorylation sites at S611, T613, and T616. Several studies
have demonstrated that PKC modulators, such as bPMA, reduce
SERT localization on the plasma membrane and blunt 5HT
uptake capacity [1,11,12,22,23,25–28]. Additionally, these studies
also established an interaction of PP2A, a component of the
protein phosphatase complex, with SERT [29–31]. Based on these
findings, we analyzed the effects of phosphorylation-mimicking
amino acids on the 5HT uptake rate of SERT. Our results
indicate that S611 may be a key site for phospho-regulation, since
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Figure 6. Vimentin binding ability of SITPET mutants. CHO cells
expressing the indicated SERT constructs were lysed and prepared for
IP. The cell lysate was incubated with anti vimentin-Ab coated protein A
sepharose beads. The presence of SERT truncations was detected with a
polyclonal SERT Ab (Chemicon International). Nonspecific adsorption of
Sepharose beads was not determined in the absence of vimentin-Ab
and the data obtained from this set of experiment is not presented here
since it can be found in Figure 1B. All lanes contain protein recovered
from the same number of cells equivalent to one of well from a
confluent 24-well culture plate. The triple mutant AAA and two of the
single mutants, T613D and T616D, bound to vimentin; S611D showed a
low affinity for binding to vimentin. Figure shows representative images
from 3 separate experiments.
doi:10.1371/journal.pone.0004730.g006
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PLoS ONE | www.plosone.org 10 March 2009 | Volume 4 | Issue 3 | e4730the single mutation of S611 to D caused a 61% decrease in 5HT
uptake rate whereas the single mutation of S611 to A caused no
reduction in 5HT uptake. T613 and T616 individually do not
appear to be critical phospho-regulatory residues since neither
mutation (A or D) of T613 and T616 showed a similar level of
5HT uptake rate. However, it is possible that these sites work in
conjunction with each other to modulate the function of the
transporter since our results indicate that the triple mutation DDD
of 611, 613, and 616 retained only 5% of its 5HT uptake capacity
as compared to control SERT. It is also important to note that the
presence of such a large amount of negative charge on the end of
the protein could cause alterations in protein folding or protein-
protein associations that are important for protein function,
resulting in the observed blunting of transport capacity.
Next, we analyzed the impact of four truncations of the SERT
C-terminus on the trafficking and expression of SERT on the
Figure 7. Impact of 5HT stimulation on the plasma membrane density of truncated and mutant transporters. CHO cells expressing
truncated or mutant forms of transporter were either directly (A and B) or after stimulated with 100 mM 5HT (C and D) subjected to the cell surface
biotinylation assays. Biotinylated membrane proteins were pulled down on streptavidin beads and eluted from the beads in SDS-PAGE sample buffer.
The biotinylated eluents were subjected to immunoblot analysis using either anti-SERT (A and C), or anti-vimentin (B), or pS56-Ab (D). All lanes
contain protein recovered from the same number of cells equivalent to one of well from a confluent 24-well culture plate. In the surface protein
experiments, we included two control experiments: mock biotinylated CHO cells transfected with SERT and mock transfected CHO cells. The first
control, mock biotinylated CHO cells, were carried through the biotinylation procedure without the addition of the biotinylation reagent and neither
of antibodies, SERT-, vimentin- nor pS56-Abs recognized proteins from these blots (data not presented). The next control, mock-transfected cells
allowed us to observe (i) the nonspecific absorption of Sepharose beads and the proteins from the detergent soluble platelet lysate; (ii) if 5HT
mediate any of these nonspecific interactions. Pretreatment with 100 mM 5HT increased the density of D14 and S611D, significantly or partially,
respectively, and decreased the density of wild-type SERT and the truncated or mutant transporters which could to the plasma membrane. The
transporters whose surface expressions were decreased with 5HT-stimulation, i.e., wild-type, D6, AAA, T616D, and T613D, were able to bind vimentin
(B) and phosphovimentin (D). However, the truncated or mutant forms transporters which could not bind vimentin (B) and appeared on the plasma
membrane at high levels in 5HT-stimulation (C), such as D14 and S611D, could not bind phosphovimentin (D), either. The total phosphovimentin (E)
and vimentin (F) (as flow through of the streptavidin beads) did not differ in truncated and mutant forms of transporter expressing CHO cells. The
levels of vimentin and phosphovimentin in cell lysate of 100 mM 5HT-stimulated cells show if the associations between these proteins with SERT or
truncated/mutant forms are altered with the differences in their levels, and/or with 5HT stimulation (Figure 7E and F). All lanes contain protein
recovered from the same number of cells equivalent to 30% of one well from a confluent 24-well culture plate.
doi:10.1371/journal.pone.0004730.g007
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indicate that depending on the amount of truncation from the C-
terminus of SERT, there was altered localization of the
transporter. Therefore, we carried out a biotinylation analysis on
some of the phosphorylation-mimicking mutations in an effort to
determine the plasma membrane localization of these mutants,
i.e., whether the mutation arrests them intracellularly or whether
the mutants can still traffic to the plasma membrane. The data
indicate that 3 possible phosphorylation sites do contribute to the
5HT uptake rates of transporters via inhibiting their proceedings
toward the plasma membrane. The proteins involved in the
membrane trafficking of SERT are still under investigation by
many laboratories.
Our biochemical and proteomic analysis of the platelet proteins
associated with the C-terminus of SERT demonstrate an
association between vimentin, an intermediate filament, and
SERT in platelets. Association also was noted in a CHO
heterologous expression system. Vimentin is the major type III
intermediate filament expressed in cells of mesenchymal (e.g.
endothelium, fibroblasts, megakaryocytes) and myogenic origin
Figure 8. Effect of SERT-vimentin interaction on the surface expression of SERT. (A) CHO-SERT cells were pretreated with 0, 10, or 100 mM
5HT and biotinylated with NHS-SS-biotin (15, 16, 19). Biotinylated plasma membrane proteins were retrieved on streptavidin beads and analyzed for
SERT or phosphovimentin- (pS56-) Ab by W/B. All lanes contain protein recovered from the same number of cells equivalent to one well from a
confluent 24-well culture plate. (B) Intracellular SERT, vimentin, and phosphovimentin were also determined by W/B analysis of non-bound material.
Mock-transfected CHO cells served as a control. Vimentin served as a loading control. The results of W/B analysis are the summaries of combined data
from three densitometric scans. * represent differences from 0 mM 5HT-matched samples. All lanes contain protein recovered from the same number
of cells equivalent to 30% of one well from a confluent 24-well culture plate. (C) CHO cells expressing SERT and phosphovimentin mutant S56A were
first pretreated with (0–100 mM) 5HT, and then their 5HT uptake rates were measured in intact cells as described under ‘‘Materials and Methods.’’
Background accumulation of (
3H)-serotonin was measured in the same experiment using mock-transfected cells and subtracted from each
experimental value. Maximum background accumulation was 0.01 pmol/mg protein/min. Rate of uptake is expressed as the means and SD values of
triplicate determinations from three independent experiments. ANOVA indicated that the interaction between 5HT level and cell line was highly
significant (p,0.001) for both figures (B and C). Post-hoc comparisons were adjusted using a Bonferroni correction. Significant comparisons with the
uptake rates of mock transfected CHO cells within 5HT level are indicated with *, and with 0 mM 5HT within cell line are indicated with # (all
p#0.001).
doi:10.1371/journal.pone.0004730.g008
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[33], is associated with the Triton X-100 insoluble fraction of
human platelets [34,35]. Studies have shown that vimentin forms a
network of intermediate filaments that form a ring close to the cell
membrane, as well as a network that activates PAK-dependent
phosphorylation of vimentin, altering the filamentous structure of
this cytoskeletal compound. Our studies demonstrate an associa-
tion between vimentin and SERT in the cytosol and on the plasma
membrane of platelet and CHO-expression system within 5HT-
independent manner. Collectively, these findings point to vimentin
as a possible candidate for facilitating the translocation of SERT
between intracellular compartments and plasma membrane.
When 5HT-stimulation dependent phosphorylation was eliminat-
ed, the surface expression and the 5HT uptake rates of SERT
were restored in CHO cells treated with 100 mM 5HT. Of the
several C-terminus mutant transporters, only D14 and S611D did
not associate with vimentin although both could appear on the
plasma membrane in active form. Additionally, neither the plasma
membrane expressions of these two mutant transporters were
decreased in 100 mM 5HT-treated cells, nor they were able to bind
phosphovimentin. These data strengthen our hypothesis that the
modification of the SITPET sequence differentially, one amino
acid at a time, exposes the vimentin binding domain on the C-
terminus of SERT. However, elevated plasma 5HT controls the
cellular distribution of SERT on an ‘‘altered’’ vimentin network,
the translocation of SERT from the plasma membrane is
accelerated on the 5HT-altered vimentin network. Thus, in
plasma of hypertensive subjects in which 5HT reaches a high level,
the platelet SERT may continue to clear plasma 5HT with a lower
Vmax, most likely until the plasma 5HT levels come back to the
physiological level [16].
Therefore, to the best of our knowledge, this is the first study to
identify a sequence on the C-terminus of SERT that regulates the
rate of 5HT uptake by altering the density of SERT on the plasma
membrane via differential phosphorylation of SITPET sequence,
which facilitates the association of SERT with an intermediate
filament, vimentin.
Recent investigations indicate a system of phosphorylation for
SERT that incorporates two phases of phosphorylation [11]. The
first phase of phosphorylation is said to affect the serine residues,
whereas the second phase involves the threonine residues. It is
suggested that the first phase of phosphorylation causes the
transporters to shut down, and the second phase of phosphory-
lation tags the proteins for internalization via the SERT recycling
mechanism. According to the biphasic model, a S611D construct
should shut down the uptake ability of the transporter while the
DD construct should demonstrate a reduced or eliminated 5HT
uptake capacity due to its intracellular localization. Indeed, our
data agree with the study by Jayanthi et al. [11], who reported that
S611D reduces transport capacity by ,39%, whereas DD
(T613+T616) demonstrates an uptake capacity of ,16%. On
the basis of our findings, we hypothesize that the blunted activity
(,39%) of S611D may be due to additional serine residues that
play a role in reducing the uptake capacity of SERT. A finding
that was not consistent with the biphasic theory was the
localization of S611D, which is mainly found at intracellular
locations.
In summary, in an endogenous platelet system and in
heterologous expression systems, our studies demonstrate that
vimentin associates with SERT. The last 20 amino acids from the
C-terminus of SERT are required and are at least one of the
binding-domain(s) of vimentin. SERT becomes a bridge between
vimentin and the plasma membrane. At physiological plasma 5HT
levels, vimentin-SERT association was found at intracellular
locations and on the plasma membrane (Fig. 7B). However, when
plasma 5HT level was higher than physiological level, their
association was enhanced and the level of SERT on the plasma
membrane was decreased. Therefore, we hypothesize that SERT
utilizes the vimentin network during translocation from the plasma
membrane. Furthermore, the 5HT-dependent phosphorylation of
vimentin on the S56 residue accelerates the translocation of SERT
on the 5HT-altered vimentin network. Future analysis of these
mutants in stable transfection systems, as well as continued
experiments with the phospho-mimicking mutants presented here,
will further reveal the mechanism of action that governs
transporter C-terminal phosphorylation. These studies also will
advance our understanding of the specific processes by which
phosphorylation of the C-terminus plays a role.
Supporting Information
Table S1
Found at: doi:10.1371/journal.pone.0004730.s001 (0.03 MB
PDF)
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Table 2. Effect of 5HT pretreatment on SERT Expression.
Percent change of SERT in 5HT pretreated cells compare to untreated cells
CHO-SERT CHO-(SERT+S56A) CHO-SERT CHO-(SERT+S56A)
SERT expression on cell membrane SERT expression in cell lysate
10 mM (5HT)ex 44.4% q 47% q 35% Q 35% Q
100 mM (5HT)ex 5.7% Q 40% q 5% q No change
In CHO-SERT and CHO-(SERT+S56A) cells, the effect of 5HT pretreatment on the surface density of SERT proteins was tested at two different concentrations: at low (10
mM) and high (100 mM) 5HT. Twenty-four hour post-transfected cells were pretreated with 5HT and biotinylated with NHS-SS-biotin [18,23,26]. Intracellular SERT and
biotinylated plasma membrane proteins were analyzed with W/B with SERT antibodies. The results of W/B analysis are the summary of combined data from three
densitometric scans denoted as the percent change of SERT density in 5HT pretreated cells compared to untreated cells.
doi:10.1371/journal.pone.0004730.t002
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